Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 06, 2024 06:00 ET | Source: Research Nester

Non-Alcoholic Steatohepatitis Treatment Market revenue to reach USD 48.3 Billion by 2035, says Research Nester

New York , March 06, 2024 (GLOBE NEWSWIRE) -- The global non-alcoholic steatohepatitis treatment market size is predicted to expand at 18% CAGR between 2023 and 2035. The market is projected to...
May 04, 2022 08:37 ET | Source: The Insight Partners

Non-Alcoholic Steatohepatitis (NASH) Market Worth $24.26Bn, Globally, by 2028 at 47.1% CAGR - Exclusive Report by The Insight Partners

New York, May 04, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Non-Alcoholic Steatohepatitis (NASH) Market Forecast to 2028 - COVID-19 Impact and Global Analysis...
August 25, 2021 09:23 ET | Source: Research and Markets

Global Antidiabetic Drug Markets Report 2021: A-Glucosidase Inhibitors, Biguanides, DPP-IV Inhibitors, Meglitinides, Sulfonylureas, Thiazolidinediones - Forecast to 2026

Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "Global Antidiabetic Drug Market (2021-2026) by Drug Type, Diabetic Type, Patient, Geography, Competitive Analysis and the Impact of Covid-19 with...
February 27, 2019 08:33 ET | Source: Reports And Data

Non-Alcoholic Steatohepatitis (NASH) Market To Reach USD 13.38 Billion By 2026 | Reports And Data

Increasing prevalence of obesity coupled with rising adoption of sedentary lifestyle is the major factor influencing market growth. Market Size – USD 0.41 billion in 2018, Market Growth - CAGR of...